NO20091771L - Ny krystall av (S)-(+)-2-(2-klorfenyl)-2-hydroksyetylkarbamat - Google Patents
Ny krystall av (S)-(+)-2-(2-klorfenyl)-2-hydroksyetylkarbamatInfo
- Publication number
- NO20091771L NO20091771L NO20091771A NO20091771A NO20091771L NO 20091771 L NO20091771 L NO 20091771L NO 20091771 A NO20091771 A NO 20091771A NO 20091771 A NO20091771 A NO 20091771A NO 20091771 L NO20091771 L NO 20091771L
- Authority
- NO
- Norway
- Prior art keywords
- hydroxyethylcarbamate
- chlorophenyl
- crystal
- fresh crystal
- fresh
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Liquid Crystal Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82839206P | 2006-10-06 | 2006-10-06 | |
| PCT/US2007/021502 WO2008045391A2 (en) | 2006-10-06 | 2007-10-05 | Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20091771L true NO20091771L (no) | 2009-05-05 |
Family
ID=39283405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20091771A NO20091771L (no) | 2006-10-06 | 2009-05-05 | Ny krystall av (S)-(+)-2-(2-klorfenyl)-2-hydroksyetylkarbamat |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7632963B2 (es) |
| EP (1) | EP2076258A4 (es) |
| JP (1) | JP2010505856A (es) |
| KR (1) | KR20090076958A (es) |
| CN (1) | CN101657195A (es) |
| AU (1) | AU2007307029A1 (es) |
| BR (1) | BRPI0718131A2 (es) |
| CA (1) | CA2665573A1 (es) |
| CO (1) | CO6180504A2 (es) |
| CR (1) | CR10764A (es) |
| EA (1) | EA200970355A1 (es) |
| GT (1) | GT200900076A (es) |
| IL (1) | IL198016A0 (es) |
| MX (1) | MX2009003755A (es) |
| NI (1) | NI200900050A (es) |
| NO (1) | NO20091771L (es) |
| SV (1) | SV2009003211A (es) |
| WO (1) | WO2008045391A2 (es) |
| ZA (1) | ZA200903095B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| WO2013100567A1 (en) * | 2011-12-27 | 2013-07-04 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain |
| KR102399807B1 (ko) * | 2021-08-05 | 2022-05-20 | (주)바이오팜솔루션즈 | 페닐카바메이트 결정형 및 이의 제조 방법 |
| WO2023014160A1 (ko) * | 2021-08-05 | 2023-02-09 | (주)바이오팜솔루션즈 | 페닐카바메이트 결정형 및 이의 제조 방법 |
| US12054449B2 (en) | 2021-08-05 | 2024-08-06 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate crystalline form and method for manufacturing the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698588A (en) | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| CA2349663C (en) | 1999-09-10 | 2006-10-31 | Dainippon Ink And Chemicals, Inc. | Quinolinone derivative formulation and its production method |
| RS51055B (sr) * | 2001-02-27 | 2010-10-31 | Ortho-Mcneil Pharmaceutical Inc. | Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neurodegenerativnih poremećaja |
| BR0215237A (pt) * | 2001-12-21 | 2004-11-16 | Ortho Mcneil Pharm Inc | Processo para a preparação de carbamatos de 2-(fenil substituìdo)-2-hidróxi-etila |
| AU2004265021B2 (en) | 2003-08-18 | 2010-05-27 | H. Lundbeck A/S | Succinate and malonate salt of trans-4-(IR,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament |
| KR20070057939A (ko) * | 2004-09-16 | 2007-06-07 | 얀센 파마슈티카 엔.브이. | 간질형성 및 간질을 치료하는 방법 |
| US20070021500A1 (en) * | 2005-07-12 | 2007-01-25 | Twyman Roy E | Methods for neuroprotection |
-
2007
- 2007-10-05 CN CN200780045483A patent/CN101657195A/zh active Pending
- 2007-10-05 EA EA200970355A patent/EA200970355A1/ru unknown
- 2007-10-05 JP JP2009531487A patent/JP2010505856A/ja not_active Withdrawn
- 2007-10-05 US US11/867,803 patent/US7632963B2/en not_active Expired - Fee Related
- 2007-10-05 EP EP07839353A patent/EP2076258A4/en not_active Withdrawn
- 2007-10-05 WO PCT/US2007/021502 patent/WO2008045391A2/en active Application Filing
- 2007-10-05 AU AU2007307029A patent/AU2007307029A1/en not_active Abandoned
- 2007-10-05 BR BRPI0718131-0A2A patent/BRPI0718131A2/pt not_active IP Right Cessation
- 2007-10-05 KR KR1020097009191A patent/KR20090076958A/ko not_active Application Discontinuation
- 2007-10-05 CA CA002665573A patent/CA2665573A1/en not_active Abandoned
- 2007-10-05 MX MX2009003755A patent/MX2009003755A/es active IP Right Grant
-
2009
- 2009-04-03 NI NI200900050A patent/NI200900050A/es unknown
- 2009-04-03 SV SV2009003211A patent/SV2009003211A/es not_active Application Discontinuation
- 2009-04-05 IL IL198016A patent/IL198016A0/en unknown
- 2009-04-06 GT GT200900076A patent/GT200900076A/es unknown
- 2009-04-07 CO CO09035814A patent/CO6180504A2/es not_active Application Discontinuation
- 2009-05-05 NO NO20091771A patent/NO20091771L/no not_active Application Discontinuation
- 2009-05-05 ZA ZA200903095A patent/ZA200903095B/xx unknown
- 2009-05-05 CR CR10764A patent/CR10764A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008045391A2 (en) | 2008-04-17 |
| US7632963B2 (en) | 2009-12-15 |
| SV2009003211A (es) | 2009-11-24 |
| CO6180504A2 (es) | 2010-07-19 |
| ZA200903095B (en) | 2010-07-28 |
| US20080085930A1 (en) | 2008-04-10 |
| EP2076258A4 (en) | 2011-09-28 |
| CR10764A (es) | 2009-09-14 |
| JP2010505856A (ja) | 2010-02-25 |
| GT200900076A (es) | 2010-05-18 |
| CA2665573A1 (en) | 2008-04-17 |
| BRPI0718131A2 (pt) | 2013-11-05 |
| AU2007307029A1 (en) | 2008-04-17 |
| KR20090076958A (ko) | 2009-07-13 |
| CN101657195A (zh) | 2010-02-24 |
| WO2008045391A3 (en) | 2008-06-12 |
| EA200970355A1 (ru) | 2009-12-30 |
| NI200900050A (es) | 2010-02-01 |
| MX2009003755A (es) | 2009-07-10 |
| EP2076258A2 (en) | 2009-07-08 |
| IL198016A0 (en) | 2009-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201000642A1 (ru) | 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы | |
| EA201070786A1 (ru) | Бензофуропиримидиноны | |
| PH12014500053A1 (en) | Proteasome inhibitors | |
| NO20084652L (no) | Deazapuriner anvendelige som inhibitorer av januskinaser | |
| EA200970581A1 (ru) | Кристаллическое твёрдое основание разагилина | |
| NO20092637L (no) | Fremgangsmater for behandling | |
| NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
| NO20092584L (no) | Farmasoytiske sammensetninger og deres fremgangsmater for anvendelse | |
| EA201200669A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
| CY1112653T1 (el) | Κρυσταλλικες τροποποιησεις της πυρακλοστροβινης | |
| EA201170508A1 (ru) | Производные 1-амино-2-циклобутилэтилбороновой кислоты | |
| EA200970156A1 (ru) | Пиридизиноновые производные | |
| EA200800760A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
| EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
| NO20090596L (no) | Antivirale fosfinatforbindelser | |
| TW200621721A (en) | Methods of preparing indazole compounds | |
| NO20090157L (no) | Tienpyrimidiner anvendelige som modulatorer av ionekanaler | |
| NO20080141L (no) | Indanderivater som modulatorer av ionekanaler | |
| EA201170703A1 (ru) | Производные адамантилбензамида | |
| DK3072507T3 (da) | Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi | |
| EA201401193A1 (ru) | Триарильные соединения и композиции, их содержащие | |
| EA201070424A1 (ru) | Хиназолиндионовые производные, их получение и их применения в терапии | |
| EA201070009A1 (ru) | Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии | |
| EA200801414A1 (ru) | Кальцилитические соединения | |
| EA201000391A1 (ru) | Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |